Christopher J Destache (Chris Destache)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 12

Top Venues

Antimicrobial agents and chemotherapy

Pharmacy (Basel, Switzerland)

Antibiotics (Basel, Switzerland)

Microorganisms

Creighton University School of Pharmacy & Health Professions

Creighton University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Creighton University School of Pharmacy & Health Professions Jul 1o 1985

United States

Professor :: Pharmacy Practice

Education History

Creighton University Aug 15o 1980

United States

PHD

Publications

Richard Swaney, Rutendo Jokomo-Nyakabau, Anny A N Nguyen, Dorothy Kenny, Paul G Millner, Mohammad Selim, Christopher J Destache, Manasa Velagapudi
Diagnosis and Outcomes of Fungal Co-Infections in COVID-19 Infections: A Retrospective Study. Microorganisms 11 (9) (2023)
Christopher J Destache, Faran Ahmad, Sanu Rajendrapasad, Austin Loranger, William Pruett, Nikhal Jagan, Bryan Krajicek, David Schmidt, David Quimby, Manasa Velagapudi, Dayla Boldt, Sarah Hayes, Jennifer Anthone, Brittney Kessel, Renuga Vivekanandan
COVID-19 Mortality and Therapeutics in Nebraska and Southwest Iowa during Early Pandemic. Pharmacy (Basel, Switzerland) 10 (4) (2022)
Stephen J Cooper, Christopher J Destache, Renuga Vivekanandan
Improving understanding and utilization of the antibiogram among medical residents. Antimicrobial stewardship & healthcare epidemiology : ASHE 2 (1) (2022)
William Reiche, Faith Abodunrin, Christopher J Destache, Rajani Rangray, Manasa Velagapudi
Doxycycline Induced Pancreatitis: An Uncommon Complication of a Common Drug. Pharmacy (Basel, Switzerland) 10 (6) (2022)
Subhra Mandal, Shawnalyn W Sunagawa, Pavan Kumar Prathipati, Michael Belshan, Annemarie Shibata, Christopher J Destache
Targeted Immuno-Antiretroviral to Promote Dual Protection against HIV: A Proof-of-Concept Study. Nanomaterials (Basel, Switzerland) 12 (11) (2022)
Subhra Mandal, Pavan Kumar Prathipati, Shawnalyn W Sunagawa, Christopher J Destache
A Concept Evaluation Study of a New Combination Bictegravir plus Tenofovir Alafenamide Nanoformulation with Prolonged Sustained-Drug-Release Potency for HIV-1 Preexposure Prophylaxis. Antimicrobial agents and chemotherapy 65 (4) (2021)
Eric Reid, Ryan W Walters, Christopher J Destache
Beta-Lactam vs. Fluoroquinolone Monotherapy for Pseudomonas aeruginosa Infection: A Systematic Review and Meta-Analysis. Antibiotics (Basel, Switzerland) 10 (12) (2021)
Christopher J Destache, Sarah J Aurit, David Schmidt, Laura Peet Erkes, Maureen Tierney, Renuga Vivekanandan
Bamlanivimab use in mild-to-moderate COVID-19 disease: A matched cohort design. Pharmacotherapy 41 (9) (2021)
Jennifer Anthone, Dayla Boldt, Bryan Alexander, Cassara Carroll, Sumaya Ased, David Schmidt, Renuga Vivekanandan, Christopher J Destache
Implementation of a Health-System Wide Antimicrobial Stewardship Program in Omaha, NE. Pharmacy (Basel, Switzerland) 7 (4) (2019)
Amit N Pandya, Pavan Kumar Prathipati, Pooja Hegde, Wei Li, Kyle F Graham, Subhra Mandal, Kristen M Drescher, Christopher J Destache, Diane Ordway, Mary Jackson, E Jeffrey North
Indole-2-Carboxamides Are Active against Mycobacterium abscessus in a Mouse Model of Acute Infection. Antimicrobial agents and chemotherapy 63 (3) (2019)
Subhra Mandal, Michael Belshan, Ashley Holec, You Zhou, Christopher J Destache
An Enhanced Emtricitabine-Loaded Long-Acting Nanoformulation for Prevention or Treatment of HIV Infection. Antimicrobial agents and chemotherapy 61 (1) (2016)
Christopher J Destache, Subhra Mandal, Zhe Yuan, Guobin Kang, Abhijit A Date, Wuxun Lu, Annemarie Shibata, Rachel Pham, Patrick Bruck, Michael Rezich, You Zhou, Renuga Vivekanandan, Courtney V Fletcher, Qingsheng Li
Topical Tenofovir Disoproxil Fumarate Nanoparticles Prevent HIV-1 Vaginal Transmission in a Humanized Mouse Model. Antimicrobial agents and chemotherapy 60 (6) (2016)

Christopher J Destache.css-eqlu8i{font-size:small;padding-left:4px;} (Chris Destache)

Publication Activity (10 Years)

Top Topics

Top Venues

Christopher J Destache (Chris Destache)